SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)

Autor: Jaume Capdevila Castillón, Teresa Alonso Gordoa, Alberto Carmona Bayonas, Ana Custodio Carretero, Rocío García-Carbonero, Enrique Grande Pulido, Paula Jiménez Fonseca, Angela Lamarca Lete, Angel Segura Huerta, Javier Gallego Plazas

Publikováno v: Clinical and Translational Oncology.

Neuroendocrine neoplasms (NENs) are a heterogeneous family of tumors of challenging diagnosis and clinical management. Their incidence and prevalence continue to rise mainly due to an improvement on diagnostic techniques and awareness. Earlier detect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d81804720e1a3c8ee39ff17849284a07
https://doi.org/10.1007/s12094-023-03205-6

Zolbetuximab + CAPOX in 1L claudin-18.2+ (CLDN18.2+)/HER2− locally advanced (LA) or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW

Autor: Rui-hua Xu, Kohei Shitara, Jaffer A. Ajani, Yung-Jue Bang, Peter C. Enzinger, David H. Ilson, Florian Lordick, Eric Van Cutsem, Javier Gallego Plazas, Jing Huang, Lin Shen, Sang Cheul Oh, Patrapim Sunpaweravong, Hwoei Fen Soo Hoo, Haci M. Turk, Jung Wook Park, Diarmuid Martin Moran, Pranob P. Bhattacharya, Ahsan Arozullah, Manish A. Shah

Publikováno v: Journal of Clinical Oncology. 41:405736-405736

405736 Background: There is an unmet need for novel targeted therapies that improve outcomes for pts with HER2− LA unresectable or mG/GEJ adenocarcinoma. CLDN18.2 is expressed in normal gastric mucosa cells and retained in most G/GEJ adenocarcinoma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c26daf893e8181bc9951e77460017a36
https://doi.org/10.1200/jco.2023.41.36_suppl.405736

SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)

Autor: Ana Fernández-Montes, Julia Alcaide, María Alsina, Ana Belén Custodio, Lourdes Fernández Franco, Javier Gallego Plazas, Carlos Gómez-Martín, Paula Richart, Fernando Rivera, Marta Martin-Richard

Publikováno v: Scientia
CLINICAL & TRANSLATIONAL ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Diagnosis; Esophageal cancer; Treatment Diagnóstico; Cáncer de esófago; Tratamiento Diagnòstic; Càncer d'esòfag; Tractament Esophageal cancer is an aggressive tumor, and is the sixth-leading cause of death from cancer. Incidence is rising in Sp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7573ec4bcf44240d793a5852f7f6ac42
https://pubmed.ncbi.nlm.nih.gov/35347573

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL)

Autor: Zev A. Wainberg, David Ferry, Ravindranath Patel, Denis Pezet, Elzbieta Wojcik, Kazumasa Fujitani, Vera Gorbounova, Fernando Cabanillas, Bela Piko, Fidel David Huitzil Melendez, Agnes Ruzsa, Jean-Marc Phelip, Madhuri Bajaj, J.T. Beck, Elizabeth Won, Alexander Luft, Sara Lonardi, Peter C. Enzinger, Maen A. Hussein, Bohuslav Melichar, Daisuke Sakai, Angel Gomez Villanueva, A Madi, Georgina Garnica Jaliffe, Carlo Barone, Guillermo Mendez, Marina N. Nechaeva, György Bodoky, Hubert Ayala, Francesco Di Costanzo, Julien Taieb, David H. Ilson, Leslie Samuel, Ronald L. Burkes, Mayukh Das, Marc Van den Eynde, Charles S. Fuchs, Scott M. Berry, Ji Lin, Shuichi Hironaka, Christina Maria Gomez, Thierry Alcindor, Eric Van Cutsem, James A. Jr Reeves, Katriina Peltola, Timothy R. Asmis, Christine Brezden-Masley, Udit Verma, Javier Gallego Plazas, Isabelle Sinapi, Peter Bono, Nozomu Machida, Cynthia Coo Chua, Francisco Javier Ramirez Godinez, Annemieke Cats, Raija Kallio, Alex Beny, Hiroki Hara, Cardellino Giovanni Gerardo, Diego Lucas Kaen, Wasat Mansoor, Miguel Angel Escudero, Andràs Csilla, Akihito Tsuji, Ralf-Dieter Hofheinz, Jana Pribylova, Marianne Nordsmark, Daniel Dammrich, Maria Alejandra Bartoli, Joanna Pikiel, Robert Andrew Dichmann, Maria Di Bartolomeo, Ricardo Villalobos Valencia, Jill Lacy, Raymond Jang, Carlos Alberto Hernandez, Giuseppe Aprile, Nina A. Karaseva, Jonathan Wadsley, Ian Chau, Svetlana Protsenko, Jana Prausová, Maria Błasińska-Morawiec, Salah-Eddin Al-Batran, Hélène Senellart, Stephen Leong, Francisco Gutiérrez Delgado, Johanna C. Bendell, Laurent Mineur, M.I. Grootscholten, Hugo Ford, Russell D. Petty, Laura Visa Turmo, Roberto Carlesi, Hector Velez-Cortez, Maria Alsina, Jiri Petera, Seigo Yukisawa, Federico Longo Munoz, Mette Karen Yilmaz, Pilar Garcia Alfonso, Baruch Brenner, Irfan Firdaus, William E. Lawler, Sylvie Lorenzen, Moustapha Tehfe, Kohei Shitara, Naotoshi Sugimoto, Karen Geboes, A.J. Ten Tije, Walid Shaib, Shigenori Kadowaki, Nicolas Robert Maisey, H.M.W. Van Laarhoven, Radka Obermannova, F.L.G. Erdkamp, Rubén Dario Kowalyszyn, Joanna Wojcik-Tomaszewska, Peter Istvan Acs, Crystal S. Denlinger, Ravit Geva, Srinivasan Madhusudan, Brian Anthony DiCarlo, Ferdinando De Vita, Alejandro Molina Alavez, Gunnar Folprecht, Kensei Yamaguchi, Moses Sundar Raj, Judit Kocsis, Susanna Hegewisch-Becker, Joana Vidal Barrull, Daisuke Takahari, Tomasz Sarosiek, Luis Fein, Mohamed Hebbar, Tibor Csoszi, Manish A. Shah, Alfredo Falcone, Hugo Hool, Michel Ducreux, Per Pfeiffer, Einat Shacham-Shmueli, Howard J. Lim, Taito Esaki

Publikováno v: The Lancet Oncology, 20(3), 420-435. Lancet Publishing Group

Summary Background VEGF and VEGF receptor 2 (VEGFR-2)-mediated signalling and angiogenesis can contribute to the pathogenesis and progression of gastric cancer. We aimed to assess whether the addition of ramucirumab, a VEGFR-2 antagonist monoclonal a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32e40b7f9384317e149edcc0dc8725d0
https://doi.org/10.1016/s1470-2045(18)30791-5

Adenocarcinoma de apéndice con extensión extraapendicular: Análisis clínico-quirúrgico e histológico de 27 casos

Autor: Francisco José Morera Ocón, Samuel Navarro Fos, Elena Muñoz Forner, Javier Gallego Plazas, Bruno Camps Vilata, Clara Navarro Campoy

Publikováno v: Medicina Clínica. 149:153-156

Resumen Fundamento y objetivos La neoplasia apendicular con extension extraapendicular puede mostrarse con diferentes patrones clinicos, entre ellos el pseudomixoma peritoneal (PMP). Analizamos los resultados de una serie clinica tratada en nuestro c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c11420a7dce6977c73919202da49f328
https://doi.org/10.1016/j.medcli.2017.03.031